EichorEICHOR
Location: Stavanger Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Stavanger

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Stavanger Universitetssykehus ( Site 2004) · Merck Sharp & Dohme LLC · NCT06393374Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
Phase 3 · Stavanger University Hospital · Vastra Gotaland Region · NCT06419946Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma
Phase 3 · Stavanger University Hospital · Uppsala University · NCT06488482PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Helse Stavanger, Stavanger Universitetssykehus · Boehringer Ingelheim · NCT07355296Personalized Digital Treatment for Adolescent Anxiety: A Feasibility Trial
NA · Children and Adolescent Mental Health Outpatient Clinics · Helse Stavanger HF · NCT07145307A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advance
Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06885034A Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Extension Study
NA · Stavanger University Hospital · Haukeland University Hospital · NCT05095571SAINT: Safe Induction of Labor Trial
Phase 3 · Stavanger University Hospital · Oslo University Hospital · NCT05719467Stavanger University Hospital Inflammatory Bowel Disease Trial
Phase N/A · SUS · Helse Stavanger HF · NCT01551563A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · Stavanger Universitetssykehus · Eli Lilly and Company · NCT07222332ASD and Habituation to Dental Examination
NA · Oral health centre of Expertise Rogaland · Oral Health Center of Expertise Rogaland, Norway · NCT06933342A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Stavanger Universitetssykehus ( Site 1901) · Merck Sharp & Dohme LLC · NCT06077760The Benefit of Repairing the Deltoid Ligament in Unstable Ankle Fractures
NA · Stavanger University Hospital · Ostfold Hospital Trust · NCT06568276Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)
Phase 2 · Stavanger University Hospital · Helse Stavanger HF · NCT06362707A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Helse Stavanger, Stavanger Universitetssykehus · Boehringer Ingelheim · NCT07220083A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Phase 3 · Stavanger Universitetssjukehus - Helse Stavanger HF · Takeda · NCT06963827A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancre
Phase 3 · Investigative Site NO005 · Incyte Corporation · NCT07522073Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer
Phase N/A · Stavanger University Hospital · Helse Stavanger HF · NCT01762813Management of Patients With Heart Failure at Home After Hospital Discharge
NA · Stavanger University Hospital · University Hospital, Akershus · NCT06576752The NEU-STIM Trial
NA · Stavanger University Hospital · Leiden University Medical Center · NCT05942924Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial
Phase 4 · Stavanger University Hospital · Oslo University Hospital · NCT06653634A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · Stavanger Universitetssykehus · Eli Lilly and Company · NCT06119581A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Phase 2 · Site NO47001 · Astellas Pharma Global Development, Inc. · NCT02960022A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With
Phase 3 · Stavanger University Hospital Ullandhaug · Janssen Research & Development, LLC · NCT07258511A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer
Phase N/A · Stavanger University Hospital · Oslo University Hospital · NCT06944587A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in
Phase 3 · Avdeling for Blod- og Kreftsykdommer, Stavanger Universitets · Nordic Lymphoma Group · NCT04332822Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial
Phase 2 · Stavanger University Hospital · Helse Fonna · NCT04588285A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Phase 3 · Stavanger University Hospital, Dept of Haematology · Mats Heyman · NCT04307576Blood-based Biomarkers for Diagnosis of Alzheimer's
NA · Stavanger University Hospital · Helse Stavanger HF · NCT05187819Patient Trajectories for Older Adults Admitted to Hospital for Alcohol-related Problems
Phase N/A · StavangerUH · Helse Stavanger HF · NCT04164940
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.